Steve Brozak
Stock Analyst at WBB Securities
(0.01)
# 4,357
Out of 4,667 analysts
6
Total ratings
9.09%
Success rate
-37.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Steve Brozak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics | Upgrades: Strong Buy | n/a | $15.12 | - | 1 | Sep 22, 2021 | |
| OMER Omeros | Maintains: Strong Buy | $75 → $100 | $6.03 | +1,558.37% | 2 | Jun 18, 2021 | |
| RDHL RedHill Biopharma | Downgrades: Buy | $17,000 → $16,000 | $6.40 | +249,900.00% | 3 | May 28, 2021 |
Cidara Therapeutics
Sep 22, 2021
Upgrades: Strong Buy
Price Target: n/a
Current: $15.12
Upside: -
Omeros
Jun 18, 2021
Maintains: Strong Buy
Price Target: $75 → $100
Current: $6.03
Upside: +1,558.37%
RedHill Biopharma
May 28, 2021
Downgrades: Buy
Price Target: $17,000 → $16,000
Current: $6.40
Upside: +249,900.00%